MEK INHIBITOR-ASSOCIATED RETINOPATHY
Clinical trials for MEK INHIBITOR-ASSOCIATED RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new MEK INHIBITOR-ASSOCIATED RETINOPATHY trials appear
Sign up with your email to follow new studies for MEK INHIBITOR-ASSOCIATED RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Melanoma drug side effects on eyes revealed in new study
Knowledge-focused CompletedThis study examined 30 people with melanoma who were taking BRAF/MEK inhibitor drugs to see how often these drugs cause retinal changes (MEKAR) and what those changes look like. Participants had regular eye exams before, during, and after treatment. The goal was to better underst…
Matched conditions: MEK INHIBITOR-ASSOCIATED RETINOPATHY
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated May 26, 2026 06:43 UTC
-
Melanoma Drug's eye risks revealed in new study
Knowledge-focused CompletedThis study looked at 14 adults with melanoma who were taking a combination of BRAF and MEK inhibitors. Researchers wanted to understand eye changes (retinopathy) that can happen as a side effect of this treatment. They used regular eye exams and imaging to track these changes ove…
Matched conditions: MEK INHIBITOR-ASSOCIATED RETINOPATHY
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated May 07, 2026 18:43 UTC